collection
https://read.qxmd.com/read/25826595/lung-transplantation-for-cystic-fibrosis-results-indications-complications-and-controversies
#1
REVIEW
Joseph P Lynch, David M Sayah, John A Belperio, S Sam Weigt
Survival in patients with cystic fibrosis (CF) has improved dramatically over the past 30 to 40 years, with mean survival now approximately 40 years. Nonetheless, progressive respiratory insufficiency remains the major cause of mortality in CF patients, and lung transplantation (LT) is eventually required. Timing of listing for LT is critical, because up to 25 to 41% of CF patients have died while awaiting LT. Globally, approximately 16.4% of lung transplants are performed in adults with CF. Survival rates for LT recipients with CF are superior to other indications, yet LT is associated with substantial morbidity and mortality (∼50% at 5-year survival rates)...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://read.qxmd.com/read/25734735/single-vs-double-lung-transplantation-in-patients-with-chronic-obstructive-pulmonary-disease-and-idiopathic-pulmonary-fibrosis-since-the-implementation-of-lung-allocation-based-on-medical-need
#2
COMPARATIVE STUDY
Justin M Schaffer, Steve K Singh, Bruce A Reitz, Roham T Zamanian, Hari R Mallidi
IMPORTANCE: Outcomes of single- and double-lung transplantation have not been rigorously assessed since the allocation of donor lungs according to medical need as quantified by the Lung Allocation Score, which began in 2005. OBJECTIVE: To compare outcomes in single- and double-lung transplant recipients since the Lung Allocation Score was implemented. DESIGN, SETTING, AND PARTICIPANTS: In this exploratory analysis, adults with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) who underwent lung transplantation in the United States between May 4, 2005, and December 31, 2012, were identified in the United Network for Organ Sharing thoracic registry, with follow-up to December 31, 2012...
March 3, 2015: JAMA
https://read.qxmd.com/read/23821508/bronchiolitis-obliterans-syndrome-the-achilles-heel-of-lung-transplantation
#3
REVIEW
S Samuel Weigt, Ariss DerHovanessian, W Dean Wallace, Joseph P Lynch, John A Belperio
Lung transplantation is a therapeutic option for patients with end-stage pulmonary disorders. Unfortunately, chronic lung allograft dysfunction (CLAD), most commonly manifest as bronchiolitis obliterans syndrome (BOS), continues to be highly prevalent and is the major limitation to long-term survival. The pathogenesis of BOS is complex and involves alloimmune and nonalloimmune pathways. Clinically, BOS manifests as airway obstruction and dyspnea that are classically progressive and ultimately fatal; however, the course is highly variable, and distinguishable phenotypes may exist...
June 2013: Seminars in Respiratory and Critical Care Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.